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Results: The ACDS achieved or exceeded all the initial pilot 
requirements. More that the required number of audits at 
each level were performed over the initial three years. The 
audit outcomes will be presented detailing the impact the 
ACDS audits, and resulting recommendations, have had on 
radiotherapy practice. The paper will also present on how 
the staff within the ACDS engaged with the professional 
clinical workforce and provided a successful and functioning 
audit service. The paper will attempt to identify these social 
successes and how these were achieved. This will provide 
details to assist and advise those seeking to design or modify 
national or regional auditing programs. Finally the paper 
reviews the potential future for the ACDS. 
 
Conclusion: The raw number of audits indicate that the ACDS 
met the pilot program's initial auditing requirements. 
Understanding the reasons for the ACDS’ success are also 
important for ensuring an on-going service or informing and 
assisting others to establish auditing services. Within the 
ACDS, success has been highly dependent on: attracting 
quality staff who can respond with agility to changing 
situations, a high level of communication with the 
professional community, and a high level of engagement by 
the community. 
The Australian Clinical Dosimetry Service is a joint initiative 
between the Department of Health and Ageing and the 
Australian Radiation Protection and Nuclear Safety Agency 
 
EP-1560  
Is EBT-XD film suitable for linac and Gamma Knife 
radiosurgery dosimetry verification and audit? 
A. Nisbet
1St. Luke's Cancer Centre Royal Surrey County Hosp, Medical 
Physics, Guildford, United Kingdom 
1, A. Dimitriadis1, A.L. Palmer2, C.H. Clark1 
2Portsmouth Hospitals NHS Trust, Medical Physics 
Department, Portsmouth, United Kingdom 
 
Purpose or Objective: The validation of radiotherapy 
treatments by dosimetric measurement is essential for the 
introduction of new techniques, pre-treatment verification 
and dosimetry audit. Film dosimetry has the advantage of 
high spatial resolution, low energy dependence and water 
equivalence. A new film (EBT-XD) has been assessed for its 
suitability for dosimetry of stereotactic radiosurgery (SRS) 
applications. 
 
Material and Methods: Calibration curves for red, green and 
blue channels were created in the range of 0-4000 cGy for 
EBT-XD and its predecessor EBT3. Ten film pieces were 
irradiated in a nominal 6MV linac. The film was scanned using 
an EPSON Expression 11000XL scanner and the analysis was 
performed in FilmQA Pro software (Ashland ISP Inc, NJ, USA). 
Film dosimetry uncertainties were assessed for typical SRS 
fields, including lateral scanner effect at high doses. Both 
EBT-XD and EBT3 films were used in-phantom for treatment 
dose verification of typical Linac based and Gamma Knife 
(GK) stereotactic radiosurgery within the STE2EV 
anthropomorphic phantom (CIRS, VA, USA). The dosimetry 
methodology for a forthcoming UK dosimetry audit of SRS 
treatment was utilised. 
 
Results: EBT-XD film has lower optical density than EBT-3 
throughout the dose range tested. EBT-XD was more suitable 
for high-dose applications because of a lower lateral scanner 
uncertainty. For the width of the film sizes that will be used 
in the SRS audit (50 mm) and the typical doses measured, the 
lateral scanner effect was estimated to be of the range of 
0.5% for EBT-XD and 3% for EBT-3. Higher agreement between 
TPS and film dose distributions was seen for EBT-XD using 
both single and triple channel dosimetry at 2% (local 
normalization),1 mm gamma index analysis criteria, with the 
recommended triple channel used for EBT-XD having a 95.5% 
passing rate, compared to conventional single channel EBT3 
having only 89.1%. Single channel EBT-XD had 89.7% passing 
rates and triple channel EBT-3 38.9%. An example is shown in 
figure 1, of EBT-XD showing a 98.3% gamma passing rate for a 
GK radiosurgery plan at 3% (local), 1.5 mm criteria 
 
 
 
Conclusion: We have evaluated the use of a new film, EBT-
XD, for SRS dosimetry verification and demonstrated its 
suitability for a forthcoming audit of radiosurgery services in 
the UK. EBT-XD is less susceptible to lateral scanner effects 
and shows better agreement to TPS dose distributions than 
EBT-3 in linac-based radiosurgery dose verifications. EBT-XD 
also showed excellent agreement with TPS dose distributions 
in GK radiosurgery. 
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Purpose or Objective: To systematically assess VMAT 
delivery accuracy using dynamic benchmark test plans. 
 
Material and Methods: Three VMAT benchmark plans were 
generated for an Elekta Synergy linac (MLCi2) using iComCAT. 
These plans consist of square field shapes with varying field 
size and a full gantry rotation (fig.1a). First, 19 control-
points (19cp) were composed to vary dose rate, MLC 
positions, jaw and gantry speed to push dynamic parameters 
to their limit. Next the number of control-points was 
increased (i.e. 37cp and 73cp) by linear interpolation so that 
MLC, jaw and gantry motion were identical to the 19cp plan, 
but with tighter regulation of dynamic components. MLC and 
jaw errors were quantified by analyzing the linac’s log files. 
For dosimetric measurements, a 2D ionchamber array placed 
in a full scatter phantom (729 & Octavius, PTW) and the 
integral quality monitor (iQM, iRT) were used. The iQM 
contains a large area ionchamber and an inclinometer for 
real-time VMAT verification. Evaluation was performed on 
the level of cumulated delivery and control-point resolved to 
investigate the effect of increasing number of control-points. 
 
Results: Slight variations in delivery were observed for the 
three plans from log-file analysis, overall revealing very 
accurate linac control in rotational mode. The mean MLC 
error was almost identical for the three plans (0.2±0.2mm). 
Relative dosimetric evaluation by means of plan 
reproducibility resulted in γmean=0.4±0.1 (19cp), 
γmean=0.2±0.0 (37cp) and γmean=0.1±0.0 (73cp) for the 
local γ 1%/1mm criterion, respectively. Increased γ-values 
were found for inter-plan comparison: 
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γmean(19vs37cp)=0.7±0.1, γmean(19vs73cp)=0.6±0.1 and 
γmean(37vs73cp)=0.6±0.1. The cumulated iQM signal 
coincided with 2D ionchamber array measurements and 
demonstrated accurate reproducibility for all three plans 
(figure 1b). The control-point resolved analysis (fig.1c) 
consistently indicated large deviations between 19cp, 37cp 
and 73cp plans due to an imprecise data sampling 
synchronization of the preclinical version of the detector. 
The symmetry of the test plan could not be reflected by the 
iQM system, especially regarding the 19cp plan. 
 
 
 
Conclusion: Increasing the number of control-points changed 
VMAT delivery accuracy marginally. For clinical treatment 
plans this effect might not be noticeable. Observation of the 
cumulative iQM signal coincided well with dosimetric 
measurements. The VMAT benchmark plan proved to be a 
prospective tool for visualizing and understanding linac and 
detector limitations. 
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Purpose or Objective: Plan verification in complex 
treatment delivery techniques such as IMRT and VMAT is 
imperative. Although some studies have been conducted on 
pre-treatment VMAT quality assurance using PTW Octavius 4D 
systems, more works are needed to focus on complex VMAT 
plans including steep gradient regions. The aim of this study 
is to evaluate dose delivery of different VMAT plans such as 
Head and Neck (SIB: Simultaneously Integrated Boost), lung 
(SBRT: Stereotactic Body Radiation Therapy) and prostate 
(Hypo-fractionated intensity modulated arc therapy) with the 
Octavius 4D system. 
 
Material and Methods: Fifteen head and neck, lung and 
prostate VMAT plans for fifteen patients (5 patients for each 
case) were created and their respective QA plans were 
calculated. All plans were optimized and calculated using 
Monaco (version 5.0) treatment planning system, which is a 
Monte Carlo-based treatment planning system. The 2D-array 
seven29, which consists of 729 vented plane-parallel 
ionization chambers arranged in a 27 x 27 matrix with the 
spatial resolution of 10mm, embedded in Octavius 4D 
cylindrical phantom was used to measure the dose 
distribution and the measurements were done with an Elekta 
Synergy linear accelerator equipped with an Agility 160 MLC 
system. In order to reconstruct and analyze the measured 3D 
dose from each plan, the PTW VeriSoft patient plan 
verification software was used and a volumetric 3D gamma 
index analysis for both 3%/3mm and 2%/2mm criteria was 
performed to compare and evaluate the measured and 
calculated doses. In addition, in order to improve the spatial 
resolution in cranial caudal direction due to 1 cm gap across 
the chambers the second measure was done by shifting the 
array 5 mm (via couch shift) in caudal direction and merging 
the matrices with the “merge” function available in PTW 
VeriSoft. 
 
Results: The mean pass rate of volumetric 3D gamma index 
for all prostate cases was superior to 97% with 3%/3mm and 
92% with 2%/2mm criteria. However, the mean passing rate 
for lungs was lower than prostate and ranged from 93.7 to 
96.3 (3%/3mm) and from 90 to 94.1 (2%/2mm). Expectedly, 
the mean value of global gamma index for head and neck 
cases could not be better than 91.5% (ranged from 88.4 to 
96.3) and 87.3% (ranged from 82.3 to 89) for the 3%/3mm and 
2%/2mm criteria respectively. Also, merged measurements 
could increase the mean passing rate from 1% up to 3.5% in 
some complex cases (Fig.1). 
 
 
 
Fig. 1: The images (Left side) represent the failed points of a 
sample; The images (Right side) depict the average 
volumetric gamma index for prostates, lungs and HN cases in 
